Related Experiment Video
Updated: Jun 30, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
A decoy receptor antagonizes interferon mediated antiviral responses in teleost fish
Yanjie Shi1,2, Kangyong Chen3,4,5, Hui Yan1,2
1Key Laboratory of Exploration and Utilization of Aquatic Genetic Resources, Ministry of Education, Shanghai Ocean University, Shanghai, 201306, China.
Background:
Negative regulation of interferon (IFN) responses is crucial for preventing IFN-induced cellular damage and restoring immune homeostasis after viral clearance. However, whether such regulation occurs at the receptor level has not been explored in lower vertebrates.
Results:
Here we characterized a decoy receptor (CRFB15) in zebrafish, belonging to the cytokine receptor family B, that functions as a decoy receptor to antagonize IFN-mediated signaling. CRFB15 was shown to be upregulated upon viral infection. It bound to IFN ligands and suppressed STAT1 phosphorylation and downstream antiviral effector gene expression, ultimately promoting viral replication. It also interacted with IFN receptors, including CRFB1, CRFB2, and CRFB5, selectively promoting degradation of CRFB2 and CRFB5 and attenuating IFN-induced antiviral response. Furthermore, crfb15-/- zebrafish exhibited enhanced resistance to viral infection, confirming its role as a negative regulator of IFN signaling.
Conclusions:
This study establishes CRFB15 as a key negative regulator of teleost type I IFN signaling. Upon viral infection, CRFB15 is upregulated and suppresses IFN signaling through two distinct pathways: by functioning as a decoy receptor that competitively binds type I IFNs and their functional receptors, and/or by promoting the degradation of the key receptor subunits CRFB2 and CRFB5.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Experimental RNAi

